McLoud, OK, United States of America

Gary L Ferrell

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Oklahoma Medical Research Foundation. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary L Ferrell. Retrieved from https://idiyas.com/inventor/gary-l-ferrell-iyz7m5qc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gary L. Ferrell: Innovator in Protein Detection

Introduction

Gary L. Ferrell is a notable inventor based in McLoud, Oklahoma. He has made significant contributions to the field of medical research, particularly in the detection of activated protein C (APC). His work has implications for clinical diagnostics and patient care.

Latest Patents

Gary L. Ferrell holds a patent for an "Assay for rapid detection of human activated protein C and highly specific monoclonal antibody therefor." This innovative assay allows for the rapid determination of APC levels in clinical situations, enhancing the ability to diagnose and monitor various health conditions. He has developed a highly specific monoclonal antibody produced by a hybridoma cell, which is crucial for this assay.

Career Highlights

Ferrell is associated with the Oklahoma Medical Research Foundation, where he has been involved in groundbreaking research. His work has contributed to advancements in the understanding and detection of proteins that play critical roles in human health.

Collaborations

He has collaborated with esteemed colleagues such as Charles T. Esmon and Patricia C. Y. Liaw, furthering the impact of his research in the scientific community.

Conclusion

Gary L. Ferrell's contributions to the field of protein detection exemplify the importance of innovation in medical research. His patent and ongoing work continue to influence clinical practices and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…